drugset / Trial / NCT04982029
Cannabidiol on Reward- and Stress-related Neurocognitive Processes in Individuals With Opioid Use Disorder
Phase 2
Completed
15 enrolled
Brigham and Women's Hospital
Harvard Medical School (HMS and HSDM) · collab
RandomizedCrossoverTriple-blindTreatment
Summary
The purpose of this study is to determine the impact of cannabidiol on reward- and stress-related neurocognitive processes among individuals with opioid use disorder on buprenorphine or methadone treatment.
Timeline
- Start
- 2022-04-14
- Primary completion
- 2022-12-02
- Completion
- 2022-12-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cannabidiol | Other / unclassified | 600 mg | Oral |